Phibro Animal Health Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Phibro Animal Health de 33.2% y 3.1% por año respectivamente. Se prevé que el BPA crezca en un 33.3% al año. Se espera que la rentabilidad financiera sea de 18% en 3 años.

Información clave

33.2%

Tasa de crecimiento de los beneficios

33.3%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Pharmaceuticals	21.1%
Tasa de crecimiento de los ingresos	3.1%
Rentabilidad financiera futura	18.0%
Cobertura de analistas	Low
Última actualización	12 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?

Dec 23

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12

Aug 26

Phibro Animal Non-GAAP EPS of $0.36 misses by $0.02, revenue of $255.3M beats by $5.26M

Aug 24

Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?

Aug 24

Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12

Jul 29

Phibro Animal declares $0.12 dividend

Jul 25

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12

May 06

Phibro Animal Health (NASDAQ:PAHC) Has Announced A Dividend Of US$0.12

Feb 11

Phibro Animal Health (NASDAQ:PAHC) Has Re-Affirmed Its Dividend Of US$0.12

Nov 05

We Discuss Why Phibro Animal Health Corporation's (NASDAQ:PAHC) CEO Compensation May Be Closely Reviewed

Oct 26

Does Phibro Animal Health (NASDAQ:PAHC) Have A Healthy Balance Sheet?

Aug 26

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12

Jul 30

Previsiones de crecimiento de beneficios e ingresos

NasdaqGM:PAHC - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2026	1,062	36	21	99	2
6/30/2025	1,029	29	16	86	3
6/30/2024	998	15	37	103	3
12/31/2023	982	15	37	74	N/A
9/30/2023	977	21	4	40	N/A
6/30/2023	978	33	-38	13	N/A
3/31/2023	978	29	-58	-5	N/A
12/31/2022	972	36	-60	-5	N/A
9/30/2022	960	46	-36	17	N/A
6/30/2022	942	49	-5	32	N/A
3/31/2022	907	59	1	33	N/A
12/31/2021	879	53	14	44	N/A
9/30/2021	853	49	21	50	N/A
6/30/2021	833	54	19	48	N/A
3/31/2021	799	43	17	49	N/A
12/31/2020	798	44	27	59	N/A
9/30/2020	806	43	31	65	N/A
6/30/2020	800	34	25	59	N/A
3/31/2020	818	37	36	70	N/A
12/31/2019	813	38	25	59	N/A
9/30/2019	818	41	11	42	N/A
6/30/2019	828	55	17	47	N/A
3/31/2019	836	68	17	42	N/A
12/31/2018	839	73	28	50	N/A
9/30/2018	827	65	47	66	N/A
6/30/2018	820	65	51	70	N/A
3/31/2018	803	58	55	73	N/A
12/31/2017	784	62	69	88	N/A
9/30/2017	770	68	N/A	82	N/A
6/30/2017	764	65	N/A	98	N/A
3/31/2017	759	64	N/A	111	N/A
12/31/2016	752	59	N/A	79	N/A
9/30/2016	752	76	N/A	61	N/A
6/30/2016	752	83	N/A	37	N/A
3/31/2016	747	78	N/A	32	N/A
12/31/2015	751	76	N/A	49	N/A
9/30/2015	748	60	N/A	49	N/A
6/30/2015	749	60	N/A	69	N/A
3/31/2015	747	32	N/A	30	N/A
12/31/2014	733	22	N/A	9	N/A
9/30/2014	717	10	N/A	17	N/A
6/30/2014	692	-3	N/A	-1	N/A
3/31/2014	672	20	N/A	27	N/A
12/31/2013	662	18	N/A	20	N/A
9/30/2013	652	23	N/A	2	N/A
6/30/2013	653	25	N/A	1	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (33.2% al año) de PAHC es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (33.2% al año) de PAHC crezcan más rápidamente que el mercado US (14.6% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de PAHC crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (3.1% al año) de PAHC crezcan más despacio que el mercado de US (8% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 3.1% al año) de PAHC crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de PAHC sea baja dentro de 3 años (18%).

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Phibro Animal Health Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus EPS estimates fall by 43%

Phibro Animal Health Corporation Reaffirms Earnings Guidance for the Fiscal Year 2024

Price target decreased by 10% to US$11.20

Price target decreased by 25% to US$12.50

Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024

Consensus EPS estimates fall by 28%, revenue upgraded

Recent updates

Phibro Animal Health Corporation to Report Q3, 2024 Results on May 08, 2024

Chairman notifies of intention to sell stock

Upcoming dividend of US$0.12 per share

Consensus EPS estimates fall by 43%

Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12

Second quarter dividend of US$0.12 announced

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Phibro Animal Health Corporation Reaffirms Earnings Guidance for the Fiscal Year 2024

Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on March 27, 2024

Phibro Animal Health Corporation Announces Chief Financial Officer Changes, Effective February 9, 2024

Price target decreased by 10% to US$11.20

Phibro Animal Health Corporation to Report Q2, 2024 Results on Feb 07, 2024

Phibro Animal Health (NASDAQ:PAHC) Use Of Debt Could Be Considered Risky

Investor sentiment improves as stock rises 18%

Now 20% undervalued after recent price drop

Upcoming dividend of US$0.12 per share at 4.6% yield

Investor sentiment deteriorates as stock falls 16%

Price target decreased by 25% to US$12.50

Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on December 20, 2023

A Look At The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)

Phibro Animal Health Corporation to Report Q1, 2024 Results on Nov 08, 2023

Phibro Animal Health Corporation, Annual General Meeting, Nov 06, 2023

Phibro Animal Health Corporation Announces Chief Financial Officer Changes

Consensus EPS estimates fall by 28%, revenue upgraded

Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024

Full year 2023 earnings: EPS misses analyst expectations

Upcoming dividend of US$0.12 per share at 3.2% yield

Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12

Phibro Animal Health Corporation to Report Q4, 2023 Results on Aug 30, 2023

Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12

Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on September 27, 2023

Upcoming dividend of US$0.12 per share at 3.6% yield

Third quarter 2023 earnings: EPS misses analyst expectations

Phibro Animal Health Corporation Reiterates Earnings Guidance for the Year Ending June 30, 2023

Chairman notifies of intention to sell stock

Upcoming dividend of US$0.12 per share at 2.9% yield

Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Phibro Animal Health Corporation Revises Earnings Guidance for the Fiscal Year Ending June 30, 2023

Phibro Animal Health Corporation Appoints Alejandro Bernal to Its Board of Directors

Phibro Animal Health Corporation to Report Q2, 2023 Results on Feb 08, 2023

Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?

Chairman notifies of intention to sell stock

Upcoming dividend of US$0.12 per share

Consensus forecasts updated

Insufficient new directors

First quarter 2023 earnings: EPS misses analyst expectations

Phibro Animal Health Corporation Revises Earnings Guidance for the Fiscal Year Ending June 30, 2023

Phibro Animal Health Corporation Declares Quarterly Dividend, Payable on December 21, 2022

Phibro Animal Health Corporation to Report Q1, 2023 Results on Nov 09, 2022

Phibro Animal Health Corporation, Annual General Meeting, Nov 07, 2022

Price target decreased to US$18.00

Chairman notifies of intention to sell stock

Upcoming dividend of US$0.12 per share

Price target decreased to US$19.67

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12

Full year 2022 earnings: EPS misses analyst expectations

Phibro Animal Health Corporation Provides Financial Guidance for the Year Ending June 30, 2023

Phibro Animal Non-GAAP EPS of $0.36 misses by $0.02, revenue of $255.3M beats by $5.26M

Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?

Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12

Phibro Animal Health Corporation to Report Q4, 2022 Results on Aug 24, 2022

Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on September 28, 2022

Phibro Animal declares $0.12 dividend

Upcoming dividend of US$0.12 per share

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12